SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending after a strong earnings report, particularly driven by the growth in its cloud computing unit (AWS). Community members are discussing the potential for further gains and analysts are raising price targets, with some anticipating a run towards year-end. The results offer a positive outlook in contrast to some other mixed tech earnings this week.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto, crow with knife ($CAW), is gaining attention, with community members highlighting its multichain functionality across $SOL, $ETH, and $CRO. Key talking points include its burn mechanism and fully circulated supply. Community members suggest potential staking opportunities could be coming soon.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's earnings are driving significant after-hours chatter, with community members dissecting the details of iPhone sales, revenue, and forward guidance. Despite mixed reactions to specific metrics, the overall sentiment leans bullish, especially concerning the company's outlook for the holiday quarter. Traders are actively discussing potential price movements and strategizing around options following the earnings release.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending amid discussions of potential deals with South Korean companies and projections of massive chip orders through 2026, sparking community excitement. The community is buzzing about Samsung's plans to build an AI Megafactory using 50,000 NVIDIA GPUs. Broader conversations include AI hype, potential electronic waste, and comparisons to the dot-com bubble, with some analysts raising price targets.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending due to its Q3 earnings report, sparking discussions about the company's profitability and future prospects tied to Bitcoin's performance. The community is focused on whether Strategy will reach certain price targets and if it will be included in the S&P 500 index. Some traders are wary of MSTR's correlation with Bitcoin and leveraged position.

UP AND TO THE RIGHT

Traders are closely watching UPRIGHT, noting its constructive chart and breakout potential. Community sentiment suggests smart money is accumulating, anticipating a significant move as volume quietly increases. Talk centers around a strong foundation, community support, and the potential for parabolic gains.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna's stock is trending amid renewed speculation of a potential buyout or merger, with community members debating potential acquirers and fair acquisition prices. Bullish sentiment is building due to the company's mRNA platform and pipeline, particularly in oncology, while some remain skeptical, citing potential patent violation risks and upcoming earnings. Some traders are eyeing a short squeeze if the stock breaks key resistance levels.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential acquisition, fueled by competitor's bidding war and strong GLP-1 sales data from major players like Eli Lilly, leading to community discussions around potential buyout prices and strategic fits.  The focus is on Phase 3 trial results, expansion into obesity treatments, and the potential for mergers or partnerships. Upcoming presentations are highly anticipated as potential catalysts.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

Solid Power (SLDP) is trending due to its partnerships with Samsung SDI and BMW to advance all-solid-state battery technology, sparking excitement about potential commercialization and material sales. Community members are discussing the implications of these partnerships, especially compared to competitors like QuantumScape, and are closely monitoring milestones and commercialization timelines. Despite some skepticism and discussion of potential hurdles, the prevailing sentiment is optimistic regarding Solid Power's role in the future of EV batteries.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to a recent sell-off following earnings, spurred by concerns over increased AI spending and a one-time tax charge, though some view this as a buying opportunity. The community is actively discussing potential recovery, with some targeting a return to previous levels. A successful bond sale signals debt investors' confidence in Meta's long-term strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five biotech stocks, all belonging to nano-, small- or mid-cap categories, notched the highest jump in Stocktwits message volume in the week ended Feb. 14, 2025:GlycoMimetics Inc. (+550% jump in chatter)GlycoMimetics, a late-stage biotech firm developing glycobiology-based cancer therapies, saw a surge in retail interest after a minor amendment to its merger agreement with Crescent Biopharma. The update refined the financing structure but kept intact the exchange ratio and ownership split. Once the deal closes, Crescent security holders, including new investors, will own about 96.9% of the combined company. Shares are up roughly 16% year-to-date (YTD).GRAIL Inc. (+500% jump in chatter)Cancer detection firm GRAIL made waves after announcing a partnership with Quest Diagnostics (DGX) to distribute its Galleri multi-cancer early detection test. Analysts at Guggenheim viewed the move as a major step toward broader accessibility. The stock has soared over 208% YTD.ADMA Biologics Inc. (+400% jump in chatter)ADMA Biologics, a biopharma company focused on plasma-derived therapies, saw rising buzz ahead of its upcoming fourth-quarter (Q4) earnings. Last month, it issued a preliminary report projecting full-year 2024 revenue between $417 million and $425 million, with total cash holdings exceeding $100 million. Despite the strong forecast, shares remain down more than 8% YTD.Moleculin Biotech Inc. (+295% jump in chatter)Moleculin Biotech gained traction after the FDA provided guidance on its Phase 3 trial for Annamycin, a next-generation anthracycline designed to treat relapsed/refractory acute myeloid leukemia (AML) and soft tissue sarcoma lung metastases. With an adjusted trial size, the company expects its first unblinding in late 2025 and another in early 2026. Shares have climbed over 25% YTD.Exelixis Inc. (+200% jump in chatter)Exelixis, an oncology-focused biotech, saw a surge in discussions after reporting Q4 earnings that topped estimates, prompting analysts to raise their price targets. Citi highlighted continued strength in its Cabometyx franchise and pointed to Zanza as a potential blockbuster drug. Shares are up 4.35% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Equity

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.


Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation at...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders...

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders...

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and...

Integrated Media Technology Limited (<a class="mention" data-mention="$IMTE" data-symbol-id="IMTE" href="https://stocktwits.com/symbol/IMTE" target="_blank">$IMTE</a>)IMTE stock rose 5% pre-market on Wednesday, building on a 9.39% rise to close at $1.98 in the previous session.The uptick in share price comes after the company appointed Zhiyun Tan to its board of directors. Tan has over a decade of experience in business and tax advisory services. According to the tech company, Tan’s addition to the board will bolster its advisory capabilities.<figure class="image"><img style="aspect-ratio:1279/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_064506_eab9455f6b.png" alt="Screenshot 2024-10-30 064506.png" width="1279" height="286"><figcaption>IMTE's Sentiment and Message Volume on Oct 30 as of 6:45 a.m. ET | Source: Stocktwits</figcaption></figure>Stocktwits retail sentiment skyrocketed to ‘extremely bullish’ (97/100), its highest mark this year, as message volume hit a one-year peak at ‘extremely high’ (95/100).The stock has lost 23% of its value so far in 2024.GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)GlycoMimetics shares fell 16% pre-market Wednesday, following a massive 191% surge in the prior trading session, after announcing its acquisition of Crescent BioPharma, an oncology therapeutics developer focused on solid tumors.The merger has received approval from the boards of both companies, though closing remains contingent on stockholder approval and other customary conditions, with finalization expected by Q2 2025.Upon completion, GlycoMimetics plans to adopt Crescent Biopharma as its new name, marking a significant pivot in its strategic focus.<figure class="image"><img style="aspect-ratio:1280/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_065931_7a6c00f4c3.png" alt="Screenshot 2024-10-30 065931.png" width="1280" height="282"><figcaption>GlycoMimetics' Sentiment and Message Volume on Oct 30 as of 6:59 a.m. ET | Source: Stocktwits</figcaption></figure> Retail sentiment on Stocktwits has peaked for a second time this year to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.GlycoMimetics’ stock has dipped 85% so far this year.Alphabet Inc. (<a class="mention" data-mention="$GOOG" data-symbol-id="GOOG" href="https://stocktwits.com/symbol/GOOG" target="_blank">$GOOG</a>)Shares of Google-parent Alphabet rose nearly 7% pre-market Wednesday, following a 1.2% gain in the prior session, after reporting strong quarterly earnings post-market close.Alphabet posted revenue of $88.27 billion, surpassing analysts’ expectations of $86.39 billion, and earnings of $2.12 per share, topping Wall Street’s forecast of $1.84 per share.The earnings report highlighted a historic milestone for Google-owned YouTube, which generated $50 billion in revenue for the first time.<figure class="image"><img style="aspect-ratio:1277/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_071149_0e8d6e2f5c.png" alt="Screenshot 2024-10-30 071149.png" width="1277" height="282"><figcaption>Alphabet's Sentiment and Message Volume on Oct 30 as of 7:11 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock remains in the ‘extremely bullish’ (92/100) territory with an uptick in chatter to ‘extremely high’ (87/100) amid the earnings buzz.Google’s stock has gained 31% so far in 2024.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/glw-stock-makes-retail-more-bullish-after-q3-earnings/cJ2DsSpRJw">Corning Stock Boosts Retail Bullishness As Wall Street Analysts Raise Price Targets Post Q3 Earnings</a> &nbsp;

Google is among the top 3 most bullish stocks on Stocktwits today

Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today

Retail sentiment is bullish on all three stocks, driven by Google's impressive financial performance, GlycoMimetics' announcement of a merger and potential rebranding, and IMTE's recent board strengthening.

Integrated Media, GlycoMimetic, Alphabet: 3 Stocks Making Retail Most Bullish Pre-Market Today

GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GLYC_sentiment_and_message_volume_Oct_29_2d5d960690.png" alt="GLYC sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of GlycoMimetics surged over 200% on Tuesday, making it the top gainer across U.S. markets and reaching a near two-year high. The biotech firm’s rally follows news of its <a href="https://stocktwits.com/news-articles/markets/equity/glyc-stock-surges-on-acquisition-deal/cJ2uwL4RJq">acquisition agreement</a> with Crescent Biopharma, backed by a $200 million investment commitment from investors including Fairmount, Venrock Healthcare Capital, and BVF Partners.&nbsp;The combined company will operate under the Crescent Biopharma name. Retail sentiment on Stocktwits skyrocketed, shifting to “extremely bullish” (97/100) from “neutral” on Monday.Canaan Inc. ($CAN)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CAN_sentiment_and_message_volume_Oct_29_41df60828f.png" alt="CAN sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of Canaan Inc., a company focused on Bitcoin mining technology, surged nearly 20% to a three-month high on Tuesday as Bitcoin’s price reached a peak of $72,338 — its highest level since April.&nbsp;This Bitcoin surge fueled significant retail interest, causing Canaan’s Stocktwits sentiment score to jump to “extremely bullish” (97/100) from a previous “bearish” outlook.PayPal Holdings Inc. ($PYPL)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PYPL_sentiment_and_message_volume_Oct_29_7f56a8c668.png" alt="PYPL sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Despite a 3% dip following its <a href="https://stocktwits.com/news-articles/markets/equity/paypal-stock-plummets-mixed-earnings-retail-investors-bullish/cJ2un8iRJm?source_caller=ui&amp;shortlink=sefos10f&amp;pid=ds&amp;af_click_lookback=7d&amp;af_xp=custom">Q3 earnings</a> report on Tuesday, which missed revenue expectations, PayPal saw a wave of retail optimism. The earnings report did exceed profit expectations, and management’s optimistic outlook reassured many investors, lifting Stocktwits sentiment to ‘extremely bullish’ (96/100).&nbsp;The divergence between sentiment and price suggests retail investors are focusing on PayPal’s long-term potential over short-term volatility.For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/tmtg-core-civic-humana-stocks-poised-for-gains-with-trump-victory-retail-sentiment-mixed/cJ2urOCRJp">TMTG, CoreCivic, Humana Stocks Poised For Gains With Trump Victory: Retail Sentiment Mixed</a>

The most bullish stock during Tuesday's mid-day trading | Source: Pixabay

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today

Acquisition news, Bitcoin ripping higher and management’s confident commentary despite a post-earnings dip are fueling a lot of optimism 

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

Crescent Biopharma Inc.

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

GLYC
GlycoMimetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GLYC News

GLYCGlycoMimetics Inc